Showing results (71-80 of 97) with videos related to

Sort By:
Pageof 10
Neuro-Oncology|April 9, 2022
Upfront molecular targeted therapy for the treatment of BRAF-mutant pediatric high-grade gliomaTom Rosenberg, Kee Kiat Yeo, Audrey Mauguen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 14, 2020
Subependymal giant cell astrocytomas are characterized by mTORC1 hyperactivation, a very low somatic mutation rate, and a unique gene expression profileKrinio Giannikou, Zachary Zhu, Jaegil Kim, et al.
Neuro-Oncology|October 11, 2017
Pediatric low-grade gliomas: next biologically driven stepsDavid T W Jones, Mark W Kieran, Eric Bouffet, et al.
Circulation|August 19, 2024
Antisense Oligonucleotide Therapy for CalmodulinopathyRaul H Bortolin, Farina Nawar, Chaehyoung Park, et al.
Neuro-Oncology|July 31, 2024
A comparative analysis of IDH-mutant glioma in pediatric, young adult, and older adult patientsMary Jane Lim-Fat, Jennifer A Cotter, Mehdi Touat, et al.
Cancer Cell|March 6, 2026
A tumor-associated photoreceptor signature unifies distinct central nervous system malignanciesBrian L Gudenas, Shiekh Tanveer Ahmad, Bernhard Englinger, et al.
Biorxiv : the Preprint Server for Biology|February 25, 2026
Single-cell multidimensional profiling of tumor cell heterogeneity in supratentorial ependymomasDaeun Jeong, Sara G Danielli, Kendra K Maaß, et al.
Neuro-Oncology|May 23, 2022
Multi-institutional study of the frequency, genomic landscape, and outcome of IDH-mutant glioma in pediatricsKee Kiat Yeo, Sanda Alexandrescu, Jennifer A Cotter, et al.
Brain Pathology (Zurich, Switzerland)|November 25, 2021
Intracranial mesenchymal tumors with FET-CREB fusion are composed of at least two epigenetic subgroups distinct from meningioma and extracranial sarcomasEmily A Sloan, Rohit Gupta, Christian Koelsche, et al.
Pageof 10